ヘルスケアにおけるフッ素樹脂の世界市場レポート 2025年

ヘルスケアにおけるフッ素樹脂の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.8%で36億4,000万米ドルに成長します。予測期間中に予想される成長は、先進ドラッグデリバリーシステムに対する需要の高まり、手術器具におけるフッ素樹脂コーティングの使用の増加、ヘルスケアインフラへの投資の増加、感染制御に対する意識の高まり、耐熱材料に対するニーズの拡大などに起因しています。この期間に予想される主な動向には、医療用チューブ設計の革新、生体適合性ふっ素樹脂の進歩、積層造形技術の進歩、持続可能なふっ素樹脂材料の調査、ふっ素樹脂ベースのスマートデバイスの統合などがあります。

低侵襲性手術器具の需要の高まりが、ヘルスケア市場におけるふっ素樹脂の成長を牽引すると予想されます。低侵襲手術機器（MISD）は、回復時間の短縮と合併症の最小化を目的として、小さな切開創から手術を行うために使用される高度なツールです。MISDは身体的外傷を少なくし、入院期間の短縮につながるため、回復を早める必要性がこの需要拡大に拍車をかけています。フッ素樹脂は、その耐薬品性、低摩擦性、生体適合性により、これらの器具において重要な役割を果たしており、器具の性能を高め、患者の安全を確保しています。その耐久性により、正確で信頼性の高い外科手術が可能になります。例えば、2025年1月、米国を拠点とする医療機器企業であるIntuitive Surgical, Inc.は、2024年には同社の手術製品が270万件近くの手術に使用され、2023年と比較して17%増加したと報告しました。このように、低侵襲手術機器に対する需要の高まりが、ヘルスケア市場におけるフッ素樹脂の拡大に寄与しています。

ヘルスケアにおけるフッ素樹脂市場の主要企業は、医療機器や診断アプリケーションの精度と耐久性を向上させるため、フッ素樹脂ベースの流体システムなどの先進製品の開発に注力しています。このようなシステムは、ふっ素樹脂材料を利用して、医療や研究所の環境で流体の流れを正確かつ安全に管理します。耐薬品性、低摩擦性、生体適合性により、重要なヘルスケア用途で信頼性の高い性能を発揮します。例えば、スウェーデンを拠点とする流体・脱気ソリューション・プロバイダーのBiotech Fluidics ABは、2023年5月、トレーサブルで認証済みのPEEKおよびふっ素樹脂製フレキシブル・チューブの新ラインを発表しました。このチューブは、医療やライフサイエンスなどの規制環境で使用するために設計されており、ISO 10993、米国薬局方クラスVI、FDAタイトル21、EU規則1907/2006（DEHP含有量に関する）などの厳しい規格に準拠しています。完全なトレーサビリティを備えたバルク品とプレカット品の両方が入手可能なこのチューブは、必要に応じてクリーンルーム内で滅菌された状態で納入することもできます。厳格な国際規制要件を満たすよう設計されているため、安全性、生体適合性、トレーサビリティが不可欠な重要用途に適しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のヘルスケアにおけるフッ素樹脂：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のヘルスケアにおけるフッ素樹脂市場：成長率分析
• 世界のヘルスケアにおけるフッ素樹脂市場の実績：規模と成長、2019年～2024年
• 世界のヘルスケアにおけるフッ素樹脂市場の予測：規模と成長、2024年～2029年、2034年
• 世界のヘルスケアにおけるフッ素樹脂：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界のヘルスケアにおけるフッ素樹脂市場：タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• ポリテトラフルオロエチレン（PTFE）
• ポリフッ化ビニリデン（PVDF）
• フッ素化エチレンプロピレン（FEP）
• エチレンテトラフルオロエチレン（ETFE）
• ポリフッ化ビニル（PVF）
• その他のタイプ
• 世界のヘルスケアにおけるフッ素樹脂市場：形態別、実績と予測、2019年～2024年、2024年～2029年、2034年
• フィルム
• コーティング
• ラッピング
• チューブ
• 世界のヘルスケアにおけるフッ素樹脂市場：用途別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 医療機器
• 医薬品包装
• 実験装置
• 防護服
• 世界のヘルスケアにおけるフッ素樹脂市場：エンドユーザー別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 病院と診療所
• 製薬会社
• 調査室
• 契約製造組織（CMO）
• 世界のヘルスケアにおけるフッ素樹脂市場、ポリテトラフルオロエチレン（PTFE）の種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 延伸ポリテトラフルオロエチレン（ePTFE）
• バージンポリテトラフルオロエチレン
• 充填ポリテトラフルオロエチレン
• 焼結ポリテトラフルオロエチレン
• 世界のヘルスケアにおけるフッ素樹脂市場、ポリフッ化ビニリデン（PVDF）の種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• ホモポリマーポリフッ化ビニリデン（PVDF）
• 共重合体ポリフッ化ビニリデン（PVDF）
• 溶融加工可能なポリフッ化ビニリデン（PVDF）
• ポリフッ化ビニリデン（PVDF）膜
• 世界のヘルスケアにおけるフッ素樹脂市場、フッ素化エチレンプロピレン（FEP）の種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• バージンフッ素化エチレンプロピレン（FEP）
• 充填フッ素化エチレンプロピレン（FEP）
• 透明フッ素化エチレンプロピレン（FEP）
• 高メルトフローフッ素化エチレンプロピレン（FEP）
• 世界のヘルスケアにおけるフッ素樹脂市場、エチレンテトラフルオロエチレン（ETFE）の種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• バージンエチレンテトラフルオロエチレン（ETFE）
• 充填エチレンテトラフルオロエチレン（ETFE）
• エチレンテトラフルオロエチレン（ETFE）フィルム
• エチレンテトラフルオロエチレン（ETFE）コーティング
• 世界のヘルスケアにおけるフッ素樹脂市場、ポリフッ化ビニル（PVF）の種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• ポリフッ化ビニル（PVF）フィルム
• ポリフッ化ビニル（PVF）コーティング
• ラミネートポリフッ化ビニル（PVF）
• ポリフッ化ビニル（PVF）シート
• 世界のヘルスケアにおけるフッ素樹脂市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• パーフルオロアルコキシ（PFA）
• フッ素エラストマー
• クロロトリフルオロエチレン（CTFE）
• フルオロエチレンビニルエーテル（FEVE）

第7章 地域別・国別分析

• 世界のヘルスケアにおけるフッ素樹脂市場：地域別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 世界のヘルスケアにおけるフッ素樹脂市場：国別、実績と予測、2019年～2024年、2024年～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ヘルスケアにおけるフッ素樹脂市場：競合情勢
• ヘルスケアにおけるフッ素樹脂市場：企業プロファイル
  • Saint-Gobain S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Daikin Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 3M Company Overview, Products and Services, Strategy and Financial Analysis
  • Solvay S.A. Overview, Products and Services, Strategy and Financial Analysis
  • AGC Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• DuPont de Nemours Inc.
• Arkema S.A.
• Orbia
• The Chemours Company
• Datwyler
• Kureha Corporation
• Pexco
• Gujarat Fluorochemicals Ltd.
• Specialty Coating Systems Inc.
• W.L. Gore & Associates
• Duke Empirical
• Halopolymer OJSC
• Fluorotherm
• Dalau Limited
• Everflon Fluoropolymers

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ヘルスケアにおけるフッ素樹脂市場2029年：新たな機会を提供する国
• ヘルスケアにおけるフッ素樹脂市場2029年：新たな機会を提供するセグメント
• ヘルスケアにおけるフッ素樹脂市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Fluoropolymers are high-performance materials extensively used in healthcare due to their outstanding chemical resistance, biocompatibility, and ability to endure high temperatures. Their non-reactive and non-stick nature makes them highly suitable for medical devices, offering consistent performance and durability, even after repeated sterilization. Their inertness and strength also make them well-suited for fluid handling applications.

The primary types of fluoropolymers used in healthcare include polytetrafluoroethylene (PTFE), polyvinylidene difluoride (PVDF), fluorinated ethylene propylene (FEP), ethylene tetrafluoroethylene (ETFE), polyvinyl fluoride (PVF), and others. PTFE is a heat-resistant, low-friction, and chemically inert fluoropolymer valued in medical applications for its strength and biocompatibility. It is available in multiple forms such as films, coatings, wrappings, and tubings-and serves a range of uses including medical devices, pharmaceutical packaging, laboratory instruments, and protective apparel. These materials are utilized by end-users like hospitals and clinics, pharmaceutical companies, research laboratories, and contract manufacturing organizations (CMOs).

The fluoropolymer in healthcare market research report is one of a series of new reports from The Business Research Company that provides fluoropolymer in healthcare market statistics, including the fluoropolymer in healthcare industry global market size, regional shares, competitors with the fluoropolymer in healthcare market share, detailed fluoropolymer in healthcare market segments, market trends, opportunities, and any further data you may need to thrive in the fluoropolymer in healthcare industry. This fluoropolymer in healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The fluoropolymers in the healthcare market size has grown strongly in recent years. It will grow from $2.73 billion in 2024 to $2.90 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth during the historic period can be attributed to the increased adoption of medical catheters, a rise in the use of minimally invasive surgical procedures, growing demand for biocompatible materials, greater preference for disposable medical equipment, and the rising prevalence of chronic diseases.

The fluoropolymers in the healthcare market size is expected to see strong growth in the next few years. It will grow to $3.64 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth anticipated in the forecast period can be attributed to the rising demand for advanced drug delivery systems, increased use of fluoropolymer coatings in surgical instruments, growing investments in healthcare infrastructure, heightened awareness of infection control, and the expanding need for temperature-resistant materials. Key trends expected during this period include innovations in medical tubing design, advancements in biocompatible fluoropolymers, progress in additive manufacturing technologies, research into sustainable fluoropolymer materials, and the integration of smart fluoropolymer-based devices.

The rising demand for minimally invasive surgical devices is expected to drive the growth of fluoropolymers in the healthcare market. Minimally invasive surgical devices (MISDs) are advanced tools used to perform procedures through small incisions, aiming to reduce recovery time and minimize complications. This growing demand is fueled by the need for faster recovery, as MISDs cause less bodily trauma and lead to shorter hospital stays. Fluoropolymers play a crucial role in these devices due to their chemical resistance, low friction, and biocompatibility, which enhance device performance and ensure patient safety. Their durability enables precise and dependable surgical operations. For example, in January 2025, Intuitive Surgical, Inc., a U.S.-based medical device company, reported that its surgical products were used in nearly 2.7 million procedures in 2024, representing a 17% increase compared to 2023. Thus, the growing demand for minimally invasive surgical devices is contributing to the expansion of fluoropolymers in the healthcare market.

Leading companies in the fluoropolymers healthcare market are focusing on the development of advanced products, such as fluoropolymer-based fluidic systems, to improve precision and durability in medical devices and diagnostic applications. These systems utilize fluoropolymer materials to manage fluid flow accurately and safely in medical and laboratory environments. Their chemical resistance, low friction, and biocompatibility ensure reliable performance in critical healthcare uses. For example, in May 2023, Biotech Fluidics AB, a Sweden-based provider of fluidic and degassing solutions, introduced a new line of traceable, certified PEEK and fluoropolymer flexible tubing. This tubing is designed for use in regulated environments such as medical and life sciences and complies with stringent standards, including ISO 10993, US Pharmacopeia Class VI, FDA Title 21, and EU Regulation 1907/2006 (regarding DEHP content). Available in both bulk and pre-cut quantities with complete traceability, the tubing can also be delivered sterilized in cleanroom assemblies when required. It is engineered to meet rigorous international regulatory requirements, making it well-suited for critical applications where safety, biocompatibility, and traceability are essential.

In February 2024, EQT Private Equity, a Sweden-based investment firm, acquired Zeus for an undisclosed amount. Through this acquisition, EQT Private Equity intends to support Zeus's expansion and innovation in advanced polymer solutions, with a focus on the medical and high-tech sectors. Zeus is a U.S.-based company specializing in the design, development, and extrusion of fluoropolymer tubing used in medical devices.

Major players in the fluoropolymer in healthcare market are Saint-Gobain S.A., Daikin Industries Ltd., 3M Company, Solvay S.A., AGC Inc., DuPont de Nemours Inc., Arkema S.A., Orbia, The Chemours Company, Datwyler, Kureha Corporation, Pexco, Gujarat Fluorochemicals Ltd., Specialty Coating Systems Inc., W.L. Gore & Associates, Duke Empirical, Halopolymer OJSC, Fluorotherm, Dalau Limited, Everflon Fluoropolymers.

North America was the largest region in the fluoropolymers in the healthcare market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in fluoropolymers in the healthcare report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the fluoropolymers in the healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The fluoropolymers in the healthcare market consist of sales of perfluoropolyether, perfluorocyclobutyl polymers, and fluoroethylene propylene rubber. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fluoropolymer In Healthcare Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on fluoropolymer in healthcare market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for fluoropolymer in healthcare ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fluoropolymer in healthcare market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Polytetrafluoroethylene (PTFE); Polyvinylidene Difluoride (PVDF); Fluorinated Ethylene Propylene (FEP); Ethylene Tetrafluoroethylene (ETFE); Polyvinyl Fluoride (PVF); Other Types
• 2) By Form: Films; Coatings; Wrappings; Tubings
• 3) By Application: Medical Devices; Pharmaceutical Packaging; Laboratory Equipment; Protective Clothing
• 4) By End-User: Hospitals And Clinics; Pharmaceutical Companies; Research Laboratories; Contract Manufacturing Organizations (CMOs)
• Subsegments:
• 1) By Polytetrafluoroethylene (PTFE): Expanded Polytetrafluoroethylene (ePTFE); Virgin Polytetrafluoroethylene; Filled Polytetrafluoroethylene; Sintered Polytetrafluoroethylene
• 2) By Polyvinylidene Difluoride (PVDF): Homopolymer Polyvinylidene Difluoride (PVDF); Copolymer Polyvinylidene Difluoride (PVDF); Melt-processable Polyvinylidene Difluoride (PVDF); Polyvinylidene Difluoride (PVDF) Membranes
• 3) By Fluorinated Ethylene Propylene (FEP): Virgin Fluorinated Ethylene Propylene (FEP); Filled Fluorinated Ethylene Propylene (FEP); Transparent Fluorinated Ethylene Propylene (FEP); High Melt Flow Fluorinated Ethylene Propylene (FEP)
• 4) By Ethylene Tetrafluoroethylene (ETFE): Virgin Ethylene Tetrafluoroethylene (ETFE); Filled Ethylene Tetrafluoroethylene (ETFE); Ethylene Tetrafluoroethylene (ETFE) Films; Ethylene Tetrafluoroethylene (ETFE) Coatings
• 5) By Polyvinyl Fluoride (PVF): Polyvinyl Fluoride (PVF) Films; Polyvinyl Fluoride (PVF) Coatings; Laminated Polyvinyl Fluoride (PVF); Polyvinyl Fluoride (PVF) Sheets
• 6) By Other Types: Perfluoroalkoxy (PFA); Fluorinated Elastomers; Chlorotrifluoroethylene (CTFE); Fluoroethylene Vinyl Ether (FEVE)
• Companies Mentioned: Saint-Gobain S.A.; Daikin Industries Ltd.; 3M Company; Solvay S.A.; AGC Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Fluoropolymer In Healthcare Market Characteristics

3. Fluoropolymer In Healthcare Market Trends And Strategies

4. Fluoropolymer In Healthcare Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Fluoropolymer In Healthcare Growth Analysis And Strategic Analysis Framework

• 5.1. Global Fluoropolymer In Healthcare PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Fluoropolymer In Healthcare Market Growth Rate Analysis
• 5.4. Global Fluoropolymer In Healthcare Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Fluoropolymer In Healthcare Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Fluoropolymer In Healthcare Total Addressable Market (TAM)

6. Fluoropolymer In Healthcare Market Segmentation

• 6.1. Global Fluoropolymer In Healthcare Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polytetrafluoroethylene (PTFE)
• Polyvinylidene Difluoride (PVDF)
• Fluorinated Ethylene Propylene (FEP)
• Ethylene Tetrafluoroethylene (ETFE)
• Polyvinyl Fluoride (PVF)
• Other Types
• 6.2. Global Fluoropolymer In Healthcare Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Films
• Coatings
• Wrappings
• Tubings
• 6.3. Global Fluoropolymer In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medical Devices
• Pharmaceutical Packaging
• Laboratory Equipment
• Protective Clothing
• 6.4. Global Fluoropolymer In Healthcare Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Pharmaceutical Companies
• Research Laboratories
• Contract Manufacturing Organizations (CMOs)
• 6.5. Global Fluoropolymer In Healthcare Market, Sub-Segmentation Of Polytetrafluoroethylene (PTFE), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Expanded Polytetrafluoroethylene (ePTFE)
• Virgin Polytetrafluoroethylene
• Filled Polytetrafluoroethylene
• Sintered Polytetrafluoroethylene
• 6.6. Global Fluoropolymer In Healthcare Market, Sub-Segmentation Of Polyvinylidene Difluoride (PVDF), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Homopolymer Polyvinylidene Difluoride (PVDF)
• Copolymer Polyvinylidene Difluoride (PVDF)
• Melt-processable Polyvinylidene Difluoride (PVDF)
• Polyvinylidene Difluoride (PVDF) Membranes
• 6.7. Global Fluoropolymer In Healthcare Market, Sub-Segmentation Of Fluorinated Ethylene Propylene (FEP), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Virgin Fluorinated Ethylene Propylene (FEP)
• Filled Fluorinated Ethylene Propylene (FEP)
• Transparent Fluorinated Ethylene Propylene (FEP)
• High Melt Flow Fluorinated Ethylene Propylene (FEP)
• 6.8. Global Fluoropolymer In Healthcare Market, Sub-Segmentation Of Ethylene Tetrafluoroethylene (ETFE), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Virgin Ethylene Tetrafluoroethylene (ETFE)
• Filled Ethylene Tetrafluoroethylene (ETFE)
• Ethylene Tetrafluoroethylene (ETFE) Films
• Ethylene Tetrafluoroethylene (ETFE) Coatings
• 6.9. Global Fluoropolymer In Healthcare Market, Sub-Segmentation Of Polyvinyl Fluoride (PVF), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polyvinyl Fluoride (PVF) Films
• Polyvinyl Fluoride (PVF) Coatings
• Laminated Polyvinyl Fluoride (PVF)
• Polyvinyl Fluoride (PVF) Sheets
• 6.10. Global Fluoropolymer In Healthcare Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Perfluoroalkoxy (PFA)
• Fluorinated Elastomers
• Chlorotrifluoroethylene (CTFE)
• Fluoroethylene Vinyl Ether (FEVE)

7. Fluoropolymer In Healthcare Market Regional And Country Analysis

• 7.1. Global Fluoropolymer In Healthcare Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Fluoropolymer In Healthcare Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Fluoropolymer In Healthcare Market

• 8.1. Asia-Pacific Fluoropolymer In Healthcare Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Fluoropolymer In Healthcare Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Fluoropolymer In Healthcare Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Fluoropolymer In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Fluoropolymer In Healthcare Market

• 9.1. China Fluoropolymer In Healthcare Market Overview
• 9.2. China Fluoropolymer In Healthcare Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Fluoropolymer In Healthcare Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Fluoropolymer In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Fluoropolymer In Healthcare Market

• 10.1. India Fluoropolymer In Healthcare Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Fluoropolymer In Healthcare Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Fluoropolymer In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Fluoropolymer In Healthcare Market

• 11.1. Japan Fluoropolymer In Healthcare Market Overview
• 11.2. Japan Fluoropolymer In Healthcare Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Fluoropolymer In Healthcare Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Fluoropolymer In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Fluoropolymer In Healthcare Market

• 12.1. Australia Fluoropolymer In Healthcare Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Fluoropolymer In Healthcare Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Fluoropolymer In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Fluoropolymer In Healthcare Market

• 13.1. Indonesia Fluoropolymer In Healthcare Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Fluoropolymer In Healthcare Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Fluoropolymer In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Fluoropolymer In Healthcare Market

• 14.1. South Korea Fluoropolymer In Healthcare Market Overview
• 14.2. South Korea Fluoropolymer In Healthcare Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Fluoropolymer In Healthcare Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Fluoropolymer In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Fluoropolymer In Healthcare Market

• 15.1. Western Europe Fluoropolymer In Healthcare Market Overview
• 15.2. Western Europe Fluoropolymer In Healthcare Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Fluoropolymer In Healthcare Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Fluoropolymer In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Fluoropolymer In Healthcare Market

• 16.1. UK Fluoropolymer In Healthcare Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Fluoropolymer In Healthcare Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Fluoropolymer In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Fluoropolymer In Healthcare Market

• 17.1. Germany Fluoropolymer In Healthcare Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Fluoropolymer In Healthcare Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Fluoropolymer In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Fluoropolymer In Healthcare Market

• 18.1. France Fluoropolymer In Healthcare Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Fluoropolymer In Healthcare Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Fluoropolymer In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Fluoropolymer In Healthcare Market

• 19.1. Italy Fluoropolymer In Healthcare Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Fluoropolymer In Healthcare Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Fluoropolymer In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Fluoropolymer In Healthcare Market

• 20.1. Spain Fluoropolymer In Healthcare Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Fluoropolymer In Healthcare Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Fluoropolymer In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Fluoropolymer In Healthcare Market

• 21.1. Eastern Europe Fluoropolymer In Healthcare Market Overview
• 21.2. Eastern Europe Fluoropolymer In Healthcare Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Fluoropolymer In Healthcare Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Fluoropolymer In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Fluoropolymer In Healthcare Market

• 22.1. Russia Fluoropolymer In Healthcare Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Fluoropolymer In Healthcare Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Fluoropolymer In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Fluoropolymer In Healthcare Market

• 23.1. North America Fluoropolymer In Healthcare Market Overview
• 23.2. North America Fluoropolymer In Healthcare Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Fluoropolymer In Healthcare Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Fluoropolymer In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Fluoropolymer In Healthcare Market

• 24.1. USA Fluoropolymer In Healthcare Market Overview
• 24.2. USA Fluoropolymer In Healthcare Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Fluoropolymer In Healthcare Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Fluoropolymer In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Fluoropolymer In Healthcare Market

• 25.1. Canada Fluoropolymer In Healthcare Market Overview
• 25.2. Canada Fluoropolymer In Healthcare Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Fluoropolymer In Healthcare Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Fluoropolymer In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Fluoropolymer In Healthcare Market

• 26.1. South America Fluoropolymer In Healthcare Market Overview
• 26.2. South America Fluoropolymer In Healthcare Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Fluoropolymer In Healthcare Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Fluoropolymer In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Fluoropolymer In Healthcare Market

• 27.1. Brazil Fluoropolymer In Healthcare Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Fluoropolymer In Healthcare Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Fluoropolymer In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Fluoropolymer In Healthcare Market

• 28.1. Middle East Fluoropolymer In Healthcare Market Overview
• 28.2. Middle East Fluoropolymer In Healthcare Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Fluoropolymer In Healthcare Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Fluoropolymer In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Fluoropolymer In Healthcare Market

• 29.1. Africa Fluoropolymer In Healthcare Market Overview
• 29.2. Africa Fluoropolymer In Healthcare Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Fluoropolymer In Healthcare Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Fluoropolymer In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Fluoropolymer In Healthcare Market Competitive Landscape And Company Profiles

• 30.1. Fluoropolymer In Healthcare Market Competitive Landscape
• 30.2. Fluoropolymer In Healthcare Market Company Profiles
  • 30.2.1. Saint-Gobain S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Daikin Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. 3M Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Solvay S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AGC Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Fluoropolymer In Healthcare Market Other Major And Innovative Companies

• 31.1. DuPont de Nemours Inc.
• 31.2. Arkema S.A.
• 31.3. Orbia
• 31.4. The Chemours Company
• 31.5. Datwyler
• 31.6. Kureha Corporation
• 31.7. Pexco
• 31.8. Gujarat Fluorochemicals Ltd.
• 31.9. Specialty Coating Systems Inc.
• 31.10. W.L. Gore & Associates
• 31.11. Duke Empirical
• 31.12. Halopolymer OJSC
• 31.13. Fluorotherm
• 31.14. Dalau Limited
• 31.15. Everflon Fluoropolymers

32. Global Fluoropolymer In Healthcare Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Fluoropolymer In Healthcare Market

34. Recent Developments In The Fluoropolymer In Healthcare Market

35. Fluoropolymer In Healthcare Market High Potential Countries, Segments and Strategies

• 35.1 Fluoropolymer In Healthcare Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Fluoropolymer In Healthcare Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Fluoropolymer In Healthcare Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer